Common Painkillers Improves Survival For Head And Neck Cancer Patients
Regular use of a common type of medication, such as aspirin and ibuprofen, significantly improves survival for a third or more patients with head and neck cancer, a new study led by UC San Francisco has found. Non-steroidal anti-inflammatory drugs, or NSAIDs, improved the overall five-year survival rate from 25% to 78% for patients whose cancer contained a specific altered gene, known as PIK3CA, the researchers reported.